Effect of crude extract and essential oil of Cordia verbenacea in experimental periodontitis in rats

  • Fernanda Vieira Ribeiro
  • Guilherme Emerson Barrella
  • Renato Corrêa Viana Casarin
  • Fabiano Ribeiro Cirano
  • Mary Ann Foglio
  • Suzana Peres Pimentel


Aim: To evaluate the effect of crude extract and essential oil of Cordia verbenacea (C.V.), systemically administered, on ligature-induced periodontitis in rats. Methods: Periodontitis was induced in 54 Wistar rats: one of the first mandibular molars was randomly assigned to receive a ligature, whereas the contralateral molar was left unligated. Then, animals were randomly assigned to one of the following groups: non-treatment group (n=18): animals that received 10 mL/day of vehicle; C.V. extract group (n=18): animals that received 100 mg/kg/day of crude extract of C.  verbenacea; and C.V. essential oil group (n=18): animals that received 100 mg/kg/day of essential oils free of C. verbenacea. All therapies were administered orally 3 times daily, for 11 days. Next, the animals were sacrificed, and the specimens were processed for morphometric analysis. Bone loss was determined on the buccal surface of the lower first molars by the distance of the cementoenamel junction from the alveolar bone. Results: Both extract and essential oil of C. verbenacea orally administered decreased alveolar bone loss in the ligated teeth when compared with the non-treated group (p<0.05). Conclusions: The present study demonstrated that systemic administration of both formulations of Cordia verbenacea may attenuate the progression of ligature induced periodontitis.


1. De Souza AP, da Silva RA, da Silva MAD, Catanzaro-Guimarães SA, Line SRP. Matrix metalloproteinases: the most important pathway involved with periodontal destruction. Braz J Oral Sci. 2005; 4: 884-90.
2. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol. 2003; 8: 12-37.
3. Gurgel BC, Duarte PM, Nociti FH Jr, Sallum EA, Casati MZ, Sallum AW, et al. Impact of an anti-inflammatory therapy and its withdrawal on the progression of experimental periodontitis in rats. J Periodontol. 2004; 75: 1613-8.
4. Holzhausen M, Spolidorio DM, Muscará MN, Hebling J, Spolidorio LC. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. J Periodontal Res. 2005; 40: 208-11.
5. Queiroz-Junior CM, Pacheco CM, Maltos KL, Caliari MV, Duarte ID, Francischi JN. Role of systemic and local administration of selective inhibitors of cyclo oxygenase 1 and 2 in an experimental model of periodontal disease in rats. J Periodontal Res. 2009; 44: 153-60.
6. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001; 345: 433-42.
7. Calixto JB, Campos MM, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 2004; 70: 93-103.
8. Cai X, Li C, Du G, Cao Z. Protective effects of baicalin on ligature-induced periodontitis in rats. J Periodontal Res. 2008; 43: 14-21.
9. Toker H, Ozan F, Ozer H, Ozdemir H, Eren K, Yeler H. A morphometric and histopathologic evaluation of the effects of propolis on alveolar bone loss in experimental periodontitis in rats. J Periodontol. 2008; 79: 1089-94.
10. Botelho MA, Martins JG, Ruela RS, I R, Santos JA, Soares JB, et al. Protective effect of locally applied carvacrol gel on ligature-induced periodontitis in rats: a tapping mode AFM study. Phytother Res. 2009; 23: 1439-48.
11. Napimoga MH, Benatti BB, Lima FO, Alves PM, Campos AC, Pena- Dos-Santos DR, et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol. 2009; 9: 216-22.
12. Sertié JA, Woisky RG, Wiezel G, Rodrigues M. Pharmacological assay of Cordia verbenacea; Part 1. Anti-inflammatory activity and toxicity of the crude extract of the leaves. Planta Med. 1988; 54: 7-10.
13. Sertié JA, Basile AC, Panizza S, Oshiro TT, Azzolini CP, Penna SC. Pharmacological assay of Cordia verbenacea. III: Oral and topical antiinflammatory activity and gastrotoxicity of a crude leaf extract. J Ethnopharmacol. 1991; 31: 239-47.
14. Sertié JA, Woisky RG, Wiezel G, Rodrigues M. Pharmacological assay of Cordia verbenacea V: oral and topical anti inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. Phytomedicine. 2005; 12: 338-44.
15. Ticli FK, Hage LI, Cambraia RS, Pereira PS, Magro AJ, Fontes MR, et al. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction. Toxicon. 2005; 46: 318-27.
16. Passos GF, Fernandes ES, Da Cunha FM, Ferreira J, Pianowski LF, Campos MM, et al. Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J Ethnopharmacol. 2007; 110: 323-33.
17. Roldão Ede F, Witaicenis A, Seito LN, Hiruma-Lima CA, Di Stasi LC. Evaluation of the antiulcerogenic and analgesic activities of Cordia verbenacea DC. (Boraginaceae). J Ethnopharmacol. 2008; 119: 94-8.
18. Fernandes MI, Gaio EJ, Oppermann RV, Rados PV, Rosing CK. Comparison of histometric and morphometric analyses of bone height in ligature-induced periodontitis in rats. Braz Oral Res. 2007; 21: 216-21.
19. Van Assche G, Rutgeerts P. Anti-TNF agents in Crohn’s disease. Expert Opin Investig Drugs. 2000; 9: 103-11.
20. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2002; 2: 364-71.
21. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001; 108: 15-23.
22. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res. 2004; 43: 33-5.
23. Sertié JA, Basile AC, Panizza S, Matida AK, Zelnik R. Anti inflammatory activity and sub-acute toxicity of artemetin. Planta Med. 1990; 56: 36-40.
24. De Carvalho PM JR, Rodrigues RF, Sawaya AC, Marques MO, Shimizu MT. Chemical composition and antimicrobial activity of the essential oil of Cordiaverbenacea D.C. J Ethnopharmacol. 2004; 95: 297-301.
25. Michielin EM, Salvador AA, Riehl CA, Smânia A JR, Smânia EF, Ferreira SR. Chemical composition and antibacterial activity of Cordia verbenacea extracts obtained by different methods. Bioresour Technol. 2009; 100: 6615-23.
26. Bezerra MM, De Lima V, Alencar VB, Vieira IB, Brito GA, Ribeiro RA, et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol. 2000; 71: 1009-14.
27. Ng VW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol. 1998; 69: 772-6.
28. Aras H, Caðlayan F, Güncü GN, Berberoðlu A, Kilinç K. Effect of systemically administered naproxen sodium on clinical parameters and myeloperoxidase and elastase-like activity levels in gingival crevicular fluid. J Periodontol. 2007; 78: 868-73.
29. Azoubel MC, Sarmento VA, Cangussú V, Azoubel E, Bittencourt S, Cunha FQ, et al. Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation. J Periodontol. 2008; 79: 1719-25.
30. Emery P. Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheumatol Suppl. 1996; 102: 23-88.
How to Cite
RIBEIRO, Fernanda Vieira et al. Effect of crude extract and essential oil of Cordia verbenacea in experimental periodontitis in rats. Brazilian Journal of Oral Sciences, [S.l.], p. 42-46, dec. 2016. ISSN 1677-3225. Available at: <https://www.fop.unicamp.br/bjos/index.php/bjos/article/view/516>. Date accessed: 15 july 2019.
Original Research

Most read articles by the same author(s)